Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away ...

Researchers from Keele University have said there are multiple barriers preventing clinicians from prescribing alternative treatments for asthma patients, despite guidance calling for a move toward ...

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

Doctors are to be issued a “climate aware” guideline to minimise the unnecessary use of aerosol asthma medications because they ... using them but only 15% to 20% really need them.” Powder inhalers, ...

Asthma Drugs Market Oral and injectable forms are expanding, especially for patients with severe asthma and those undergoing biologic treat ...

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

With an inhaler similar to those for asthma, you breathe a fine insulin powder into your lungs. There, it enters your blood through tiny blood vessels. It works to boost your insulin levels while ...

and asthma, is producing a new generation of advanced variants, based on Maison’s ground-breaking technology but pushing the boundaries even further. Its dry powder inhaler tech, which boasts ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 10.66%, which has investors questioning if this is right time to buy.